Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Novel Oral Antivirals Against SARS-CoV-2

Hear an expert overview of emerging options for prevention and outpatient treatment of COVID-19, and learn the rationale for increased federal investment into developing oral antivirals against SARS-CoV-2.
Arthur Kim, MD
Released: August 25, 2021 Expiration: No longer available for credit

Related Content

La Dra. Cristina Mussini analiza si los antivirales contra la COVID-19 están resultando beneficiosos para la prevención y/o el tratamiento de la COVID persistente, de Clinical Care Options (CCO)

Cristina Mussini, MD Released: December 5, 2022

La dott.ssa Cristina Mussini discute se gli antivirali contro la COVID-19 si stiano dimostrando utili nella prevenzione e/o nel trattamento della Long COVID, da Clinical Care Options (CCO)

Cristina Mussini, MD Released: December 5, 2022

Cristina Mussini, MD Released: December 5, 2022

Dr Jason Farley answers frequently asked questions regarding assessment and management of acute outpatient COVID-19, from Clinical Care Options (CCO), Practicing Clinicians Exchange (PCE), and ProCE

Jason E. Farley, PhD, MPH, ANP-BC, FAAN, FAANP, AACRN Released: December 2, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Educational grant provided by:
Gilead Sciences, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings